Table 1.
Baseline characteristics of included patients
| Variable | Results |
|---|---|
| Pre-operative | |
| Male/female | 104/86 |
| Age (months) | 18.383 (7.367–49.367) |
| Weight (kg) | 9.250 (6.500–15.000) |
| PASP (mmHg) | 75.000 (67.750–82.000) |
| Diagnosis | |
| Simple CHD | 78 |
| Complex CHD | 112 |
| RACHS-1 score | |
| 1 | 12 |
| 2 | 131 |
| 3 | 44 |
| 4 | 1 |
| 5 | 2 |
| Pre-operative neutrophil (109/L) | 2.595 (1.998–3.553) |
| Pre-operative lymphocyte (109/L) | 4.625 (3.008–5.848) |
| Pre-operative NLR | 0.586 (0.404–1.022) |
| Intra-operative | |
| CPB time (min) | 61.000 (52.000–72.000) |
| Aortic clamping time (min) | 34.000 (26.750–47.000) |
| Operation time (min) | 140.000 (130.000–160.000) |
| Post-operative | |
| Post-operative neutrophil (109/L) | 9.660 (7.860–12.190) |
| Post-operative lymphocyte (109/L) | 1.490 (1.090–1.873) |
| Post-operative NLR | 6.499 (4.897–9.114) |
| ALT (U/L) | 20.550 (17.400–26.800) |
| AST (U/L) | 105.400 (80.625–133.85) |
| ALB (g/L) | 42.203 ± 3.714 |
| STB (µmol/L) | 21.370 (15.868–30.125) |
| CR (µmol/L) | 28.800 (23.000–35.000) |
| BUN (mmol/L) | 6.690 (5.365–7.903) |
| UA (µmol/L) | 312.650 (251.075–419.025) |
| LVEF (%) | 60.000 (58.000–62.000) |
| Mechanical ventilation time (h) | 22.400 (5.917–47.596) |
| ICU stay time (days) | 2.856 (0.917–5.864) |
| Total length of stay (days) | 18.000 (14.000–24.250) |
PASP: pulmonary arterial systolic pressure; CHD: congenital heart disease; RACHS-1: risk Adjustment for Congenital Heart Surgery-1;NLR: neutrophil to lymphocyte ratio; CPB: cardiopulmonary bypass;ALT: glutamic pyruvic transaminase; AST: glutamic oxaloacetic transaminase; ALB: albumin; STB: Serum total bilirubin; CR: creatinine; BUN: blood urea nitrogen; UA: uric acid; LVEF: Left ventricular ejection fraction; ICU: intensive care unit